Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inhibition”

2,168 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,168 results

Testing effectiveness (Phase 2)Study completedNCT02246595
What this trial is testing

Studying Complement Inhibition in Early, Newly Developing Septic Organ Dysfunction

Who this might be right for
Severe SepsisSeptic Shock
InflaRx GmbH 72
Testing effectiveness (Phase 2)Study completedNCT03647839
What this trial is testing

Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Australasian Gastro-Intestinal Trials Group 90
Not applicableUnknownNCT02166931
What this trial is testing

BRAND'S® Essence of Chicken in the Promotion of Resilience and Resistance to Stress-associated Cognitive Inhibition

Who this might be right for
Stress Associated Cognitive InhibitionEssence of ChickenCognition+2 more
Taipei Medical University Shuang Ho Hospital 100
Not applicableStudy completedNCT01265953
What this trial is testing

Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation

Who this might be right for
Prostate Cancer Prevention
Portland VA Medical Center 98
Post-approval studies (Phase 4)Study completedNCT00424502
What this trial is testing

MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a TNF-Blocker.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 20
Very early researchNot Yet RecruitingNCT06081153
What this trial is testing

Mechanistic Clinical Trial of PCSK9 Inhibition for AAA

Who this might be right for
Abdominal Aortic Aneurysm
University of Pennsylvania 44
Early research (Phase 1)Study completedNCT01103245
What this trial is testing

Aldosterone and the Metabolic Syndrome

Who this might be right for
Metabolic DiseasesDiabetes MellitusEndocrine System Diseases+1 more
Vanderbilt University Medical Center 69
Not applicableStudy completedNCT04862572
What this trial is testing

Investigating Disinhibitory Brain Mechanism in Tinnitus and Hearing Loss

Who this might be right for
TinnitusHearing Loss
University of Nottingham 76
Large-scale testing (Phase 3)Ended earlyNCT04876430
What this trial is testing

Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionBloodstream Infection
Hospital de Clinicas de Porto Alegre 13
Testing effectiveness (Phase 2)Study completedNCT02917993
What this trial is testing

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Incyte Corporation 59
Testing effectiveness (Phase 2)WithdrawnNCT04016116
What this trial is testing

Dual PD-1 and JAK2 Inhibition in Hematological Malignancies

Who this might be right for
CancerHematological Malignancy
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT00005906
What this trial is testing

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Who this might be right for
LymphangioleiomyomatosisLymphangiomyomasPleural Effusions+1 more
National Heart, Lung, and Blood Institute (NHLBI) 4
Testing effectiveness (Phase 2)UnknownNCT01088893
What this trial is testing

Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy

Who this might be right for
Breast Neoplasms
Organisation for Oncology and Translational Research 50
Testing effectiveness (Phase 2)WithdrawnNCT05312021
What this trial is testing

Selective PDE9 Inhibition With IMR-687 in Adults With Heart Failure With Preserved Ejection Fraction

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Cardurion Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00327171
What this trial is testing

Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

Who this might be right for
NeoplasmsCancer of the Ovary
Sanofi 218
Testing effectiveness (Phase 2)UnknownNCT04833764
What this trial is testing

Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis

Who this might be right for
Post-thrombotic SyndromeDeep Vein Thrombosis Leg
Khanh Nguyen 30
Not applicableEnded earlyNCT01567332
What this trial is testing

Evaluation of Walking After Repetitive Transcranial Magnetic Stimulation (rTMS) Inhibitory 1Hz in Vascular Hemiplegia

Who this might be right for
Hemiplegia
Nantes University Hospital 10
Not applicableStudy completedNCT00901030
What this trial is testing

Association Between Perioperative Platelet Function and Major Adverse Perioperative Events

Who this might be right for
Surgery
Hamilton Health Sciences Corporation 250
Not applicableStudy completedNCT01078363
What this trial is testing

Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy

Who this might be right for
Cardiac Allograft Vasculopathy
Stanford University 96
Post-approval studies (Phase 4)Study completedNCT02748330
What this trial is testing

Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus, Type 2
Peking Union Medical College Hospital 40
Load More Results